FDA Flags Higher Death Rates Linked to Use of Abiomed Heart Pump in Post-approval Study

FDA Flags Higher Death Rates Linked to Use of Abiomed Heart Pump in Post-approval Study

Submitted by admin on February 5, 2019 - 11:15pm
Source: 
RAPS.org
News Tags: 
Abiomed
devices
FDA
Impella RP
Headline: 
FDA Flags Higher Death Rates Linked to Use of Abiomed Heart Pump in Post-approval Study
snippet: 

A temporary heart pump manufactured by Massachusetts-based Abiomed prompted a US Food and Drug Administration letter to health care providers on Monday over an increased rate of mortality.

Do Not Allow Advertisers to Use My Personal information